Top

International Journal of Colorectal Disease

Published in:

01-12-2017 | Original Article

Management of early anal cancer: need for guidelines and standardisation

Authors: Michael P. Jones, Susan Carroll, Jarad Martin, Richard Hillman, Andrew Grulich, Dianne O’Connell, Christopher Young, Isobel Mary Poynten

Published in: International Journal of Colorectal Disease | Issue 12/2017

Abstract

Purpose

The optimal management of early squamous cell carcinoma of the anal canal (AC) is yet to be determined. This study investigated current practice in the management of early AC.

Methods

A patterns of care survey was completed by Australian surgeons and radiation oncologists. Specific topics addressed were as follows: geographical location of practice, staging of disease, treatment approaches to T1N0 tumours and grade 3 anal intra-epithelial neoplasia (AIN3) lesions, radiotherapy planning, toxicities, follow-up and clinical trial involvement.

Results

Sixty-four responses were obtained. For the management of T1N0 disease, half the respondents recommended standard dose chemo-radiotherapy (CRT) and one third recommended wide local excision (WLE). For the management of AIN3, half recommended WLE while a quarter advocated observation.

Conclusions

This study reveals a significant variation in the management of early AC. The development of guidelines specific to the treatment of early AC could standardise treatment while further research is required to define the optimal management of T1N0 AC and AIN.

Steele SR, Varma MG, Melton GB et al (2012) Practice parameters for anal squamous neoplasms. Dis Colon rectum 55:735–749. https://doi.org/10.1097/DCR.0b013e318255815e

Nelson RA, Levine AM, Bernstein L et al (2013) Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 31:1569–1575. https://doi.org/10.1200/JCO.2012.45.2524 CrossRefPubMedPubMedCentral

Jemal A, Simard EP, Dorell C et al (2013) Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. JNCI Journal of the National Cancer Institute 105:175–201. https://doi.org/10.1093/jnci/djs491 CrossRefPubMedPubMedCentral

(2017) Australian Institute of Health and Welfare (AIHW) 2017. Australian Cancer Incidence and Mortality (ACIM) books: Anal cancer. Canberra: AIHW. http://www.aihw.gov.au/acim-books/. Accessed 14 Jun 2017

Hoots BE, Palefsky JM, Pimenta JM, Smith JS (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 124:2375–2383. https://doi.org/10.1002/ijc.24215 CrossRefPubMed

De Vuyst H, Clifford GM, Nascimento MC et al (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124:1626–1636. https://doi.org/10.1002/ijc.24116 CrossRefPubMed

National Comprehensive Cancer Network (2017) Anal Carcinoma Version 2.2017) https://www.nccn.org/professionals/physician_gls/pdf/anal.pdf

Bentzen AG, Guren MG, Vonen B et al (2013) Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol 108:55–60. https://doi.org/10.1016/j.radonc.2013.05.037 CrossRefPubMed

Bentzen AG, Balteskard L, Wanderås EH et al (2012) Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol 52:736–744. https://doi.org/10.3109/0284186X.2013.770599 CrossRef

10.

Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111:330–339. https://doi.org/10.1016/j.radonc.2014.04.013 CrossRefPubMed

11.

Muirhead R, Drinkwater K, O'Cathail SM et al (2017) Initial results from the Royal College of Radiologists’ UK National Audit of Anal Cancer Radiotherapy 2015. Clin Oncol 29:188–197. https://doi.org/10.1016/j.clon.2016.10.005 CrossRef

12.

Scholefield JH, Harris D, Radcliffe A (2011) Guidelines for management of anal intraepithelial neoplasia. Color Dis 13:3–10. https://doi.org/10.1111/j.1463-1318.2010.02494.x CrossRef

13.

Alam NN, White DA, Narang SK et al (2016) Systematic review of guidelines for the assessment and management of high-grade anal intraepithelial neoplasia (AIN II/III). Color Dis 18:135–146. https://doi.org/10.1111/codi.13215 CrossRef

14.

Macaya A, Muñoz-Santos C, Balaguer A, Barberà MJ (2012) Interventions for anal canal intraepithelial neoplasia. Cochrane Database Syst Rev 12:CD009244. https://doi.org/10.1002/14651858.CD009244.pub2 PubMed

15.

Ng M, Leong T, Chander S et al (2012) Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys 83:1455–1462. https://doi.org/10.1016/j.ijrobp.2011.12.058 CrossRefPubMed

16.

Myerson RJ, Garofalo MC, Naqa El I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74:824–830. https://doi.org/10.1016/j.ijrobp.2008.08.070 CrossRefPubMed

17.

Braunholtz DA, Edwards S, Lilford RJ (2001) Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect.”. J Clin Epidemiol 54:217–224. https://doi.org/10.1016/S0895-4356(00)00305-X CrossRefPubMed

18.

Jones M, Hruby G, Solomon M et al (2015) The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis. Ann Surg Oncol 22:3574–3581. https://doi.org/10.1245/s10434-015-4391-9 CrossRefPubMed

19.

Goldman KE, White EC, Rao AR et al (2016) Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma. Practical Radiation Oncology 6:e149–e154. https://doi.org/10.1016/j.prro.2016.01.004 CrossRefPubMed

20.

Edge SB, Byrd DR, Compton CC, et al (2010) AJCC cancer staging manual, 7th edition

21.

Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792–800. https://doi.org/10.1056/NEJM200003163421107 CrossRefPubMed

22.

Alfa-Wali M, Pria AD, Nelson M et al (2016) Surgical excision alone for stage T1 anal verge cancers in people living with HIV. Eur J Surg Oncol 42:813–816. https://doi.org/10.1016/j.ejso.2016.02.253 CrossRefPubMed

23.

Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ (1997) Anal canal and perianal epidermoid cancers. J Am Coll Surg 185:494–505. https://doi.org/10.1016/S1072-7515(01)00967-X CrossRefPubMed

24.

Kachnic LA, Winter K, Myerson RJ et al (2013) RTOG 0529: a Phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86:27–33. https://doi.org/10.1016/j.ijrobp.2012.09.023 CrossRefPubMed

25.

Goodman KA, Julie D, Cercek A, Cambridge L (2017) Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated. Int J Radiat Oncol Biol Phys 98:1087–1095. https://doi.org/10.1016/j.ijrobp.2017.03.022 CrossRefPubMed

26.

Bell S PLATO: personalising anal cancer radiotherapy dose. http://www.isrctn.com/ISRCTN88455282?q=&filters=conditionCategory:Cancer&sort=&offset=6&totalResults=1847&page=1&pageSize=20&searchType=basic-search. Accessed 8 May 2017

27.

Richel O, de Vries HJC, van Noesel CJM et al (2013) Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. The Lancet Oncology 14:346–353. https://doi.org/10.1016/S1470-2045(13)70067-6 CrossRefPubMed

Title: Management of early anal cancer: need for guidelines and standardisation
Authors: Michael P. Jones
Susan Carroll
Jarad Martin
Richard Hillman
Andrew Grulich
Dianne O’Connell
Christopher Young
Isobel Mary Poynten
Publication date: 01-12-2017
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Colorectal Disease / Issue 12/2017
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-017-2913-6

ACC 2024 Congress

Springer Medicine

Management of early anal cancer: need for guidelines and standardisation

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2017

Severity of diverticulitis in patients with polycystic kidney disease without transplantation

A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial

Transanal minimally invasive surgery for rectal polyps and selected malignant tumors: caution concerning intermediate-term functional results

Low risk of complications in patients with first-time acute uncomplicated diverticulitis

Outcome one year after robot-assisted rectal cancer surgery: a consecutive cohort study

Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients